• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Bluesight Diversion Trends Report Reveals $38M Lost to Drug Waste

by Jasmine Pennic 07/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Bluesight, a provider of medication intelligence solutions, released its 2024 Diversion Trends Report, offering valuable insights for healthcare providers to improve controlled substance monitoring and patient safety.

– The report demonstrates progress in healthcare’s fight against controlled substance diversion. However, the data also highlights areas for continued improvement, particularly in waste management and medication documentation. 

The report analyzes data from January 2022 to December 2023, encompassing over 127 million controlled substance transactions across 794 hospitals and health systems in the U.S. This data reveals positive trends in diversion detection and investigation efficiency:

  • Faster Investigations: Diversion investigations are closing 37 days sooner on average, indicating improved workflows and quicker evidence gathering.
  • Reduced Discrepancies: Discrepancies in controlled substance orders, administration, waste, or returns have decreased by nearly 24% since 2022, allowing hospitals to prioritize diversion detection efforts more effectively.

Key takeaways from the report include: 

  • Waste Management: Over 16 million controlled substance packages were wasted, amounting to approximately $38M in lost cost. Additionally, Fentanyl, a powerful opioid, accounted for nearly a quarter of wasted packages.
  • Documentation Errors: Half of transaction variances resulted from incorrect documentation, highlighting the importance of accurate patient, drug, and dosage information to minimize discrepancies.
  • High-Risk Areas: The report identifies nursing (77.7%), anesthesiology (11.8%), and pharmacy (5%) as departments most frequently involved in discrepancies.
  • Top Discrepant Drugs: Fentanyl (24%), Midazolam (15%), and Hydromorphone (10%) are the medications most associated with discrepancies.

“The challenge of drug diversion is an issue for all healthcare facilities, requiring a mix of consistent monitoring supported by technology and tools to help our healthcare workers effectively do their jobs. This report is a positive reminder of the impact that new systems can have in helping to tackle this problem. However, there is still more work to be done in this area,” said Kevin MacDonald, Bluesight CEO, and co-founder. “By leveraging advanced data integration and comprehensive monitoring technology, such as ControlCheck, we are setting new standards. With our commitment to continued innovation and enhanced patient safety, we support over 850 hospitals in the critical mission to improve compliance, reduce costs and track high-risk drugs and individuals.”

Report Methodology

The report leverages data from Bluesight’s ControlCheck product, analyzing controlled substance transactions across a growing network of hospitals. The significant increase in participating hospitals (from 354 to 794) contributes to the overall rise in variances, investigations, and confirmed diversion cases.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |